Defining the peak: Point prevalence of SARS-CoV-2 using randomised sampling

Authors

  • Andre L Wattiaux Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia
  • Fiona May Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia
  • Terresa Allen Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia
  • Tracy Bladen Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia
  • Brielle Pery Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia; School of Public Health, University of Queensland, Brisbane, Queensland, Australia
  • Lisa McHugh School of Public Health, University of Queensland, Brisbane, Queensland, Australia
  • Vicki Slinko Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia; School of Public Health, University of Queensland, Brisbane, Queensland, Australia
  • Alice Sykes Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia
  • Lashan De Silva Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia; Faculty of Health Sciences and Medicine, Bond University, Australia
  • Jay Bajra Gold Coast Public Health Unit, Gold Coast Health, Queensland Health, Australia; Faculty of Health Sciences and Medicine, Bond University, Australia
  • Ross Andrews Queensland Health, Australia
  • Gulam Khandaker Central Queensland Public Health Unit, Central Queensland Hospital and Health Service, Australia

DOI:

https://doi.org/10.33321/cdi.2022.46.24

Keywords:

SARS-CoV-2, prevalence, randomised survey

Abstract

Since Queensland eased border restrictions to the rest of Australia on 13 December 2021, notified cases of Coronavirus disease 2019 (COVID-19) dramatically increased, with the SARS-CoV-2 Omicron variant now the most widespread variant of concern: 145,881 cases and 13 deaths were recorded in Queensland in the month following the opening of the border. For an effective public health response to a highly transmissible disease, it is important to know the prevalence in the community, but the exponential increase in cases meant that many with symptoms had difficulty getting tested. We implemented a surveillance program on the Gold Coast that used a modified randomised household cluster survey method to estimate the point prevalence of individuals with SARS-CoV-2 detected by polymerase chain reaction (PCR). The estimated point prevalence of SARS-CoV-2 detected by PCR on self-collected swabs was 17.2% on the first visit to households (22 January 2022). This subsequently decreased to 5.2% (5 February 2022) and finally to 1.1% (19 February 2022). Out of 1,379 specimens tested over five weeks, 63 had detected SARS-CoV-2 and 35 (55.6%) were sequenced. All were SARS-CoV-2 variant: B.1.1.529 (i.e. Omicron). This surveillance program could be scaled up or reproduced in other jurisdictions to estimate the prevalence of COVID-19 in the community.

Downloads

Download data is not yet available.

References

Menachemi N, Yiannoutsos CT, Dixon BE, Duszynski TJ, Fadel WF, Wools-Kaloustian KK et al. Population point prevalence of SARS-CoV-2 infection based on a statewide random sample – Indiana, April 25-29, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(29):960–4. doi: https://doi.org/10.15585/mmwr.mm6929e1.

Subaiya S, Tabu C, N’ganga J, Awes AA, Sergon K, Cosmas L et al. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016. PLoS One. 2018;13(7):e0199786. doi: https://doi.org/10.1371/journal.pone.0199786.

Therchilsen JH, von Buchwald C, Koch A, Dam Nielsen S, Rasmussen DB, Thudium RF et al. Self-collected versus healthcare worker-collected swabs in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2. Diagnostics (Basel). 2020;10(9):678. doi: https://doi.org/10.3390/diagnostics10090678.

Downloads

Published

26/04/22

How to Cite

Wattiaux, Andre L, Fiona May, Terresa Allen, Tracy Bladen, Brielle Pery, Lisa McHugh, Vicki Slinko, et al. 2022. “Defining the Peak: Point Prevalence of SARS-CoV-2 Using Randomised Sampling”. Communicable Diseases Intelligence 46 (April). https://doi.org/10.33321/cdi.2022.46.24.

Most read articles by the same author(s)

1 2 3 4 > >>